Please login to the form below

Not currently logged in
Email:
Password:

Incanthera appoints Laura Brogden as CFO

She joins from Summ.it

Drug development and targeted cancer medicines group Incanthera has appointed Laura Brogden as its new chief financial officer.

She said: “Having known the company for many years, I am thrilled to take the position at such a pivotal and exciting time, and I am very much looking forward to the plans ahead in the immediate future.”

With over 17 years’ industry experience, Brogen joins the University of Bradford spin-out from Summ.it, where she was responsible for a portfolio of entrepreneurial clients covering venture capital and private equity businesses.

Simon Ward, chief executive officer, Incanthera, said: “Laura is a fantastic addition to the Incanthera team, as someone well known to us through heading the finances for Incanthera at Summ.it, we are delighted that she has accepted the position within the company and the board.”

24th October 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics